Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Prasaprohyai Extract in Healthy Volunteers
NCT03077282Phase 1Completed
- Sponsor
- Thammasat University
- Start
- Apr 2018
- Primary completion
- Dec 2018
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Phase 1, open-label trial of Prasaprohyai in allergic rhinitis (AR) (2 arms), sponsored by Thammasat University. Primary endpoint: Changes of Hematology test at week 8. Started Apr 2018; status: completed.
02
Drugs
Prasaprohyai
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT03077282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03077282.